Thu, Feb 23, 2017 | updated 03:47 AM IST

Indigenous technology to bring down costs of life-saving medicines

Updated: Oct 17, 2016 12:49 IST

Chandigarh [India], Oct. 17 (ANI): Scientists at CSIR-Institute of Microbial Technology (IMTECH) have developed a technology to produce biotherapeutic proteins like Erythropoietin and Streptokinase.

The indigenous technology will bring down costs of insulin, medicines for Hepatitis B, Cancer, anaemia, heart attack and several other diseases drastically.

Currently, India imports patented Biotherapeutic proteins for production of insulin, Streptokinase (blood clot buster), Hepatitis B vaccine, etc, despite India's pre-eminence as the largest exporter of generic medicines worldwide.

Erythropoietin is a key component for anti-anaemic medicines, while Streptokinase is for treatment of blood clots that blocked arteries or lung blood clots (pulmonary embolism) as well as leg blood clots (deep venous thrombosis-DVT).

"These technologies involve expressing the genes for the therapeutic proteins in different microbial hosts like bacteria and yeasts. The latter include the well known baker's yeast and Pichia pastoris. The cost advantage and ease of production of proteins have made the recombinant yeast based technologies prevalent worldwide which hold a major share of world therapeutic protein market," said Jagmohan Singh, the Chief Scientist.

Singh has developed an indigenous technology platform for commercial scale production of Biotherapeutic Proteins to make these basic life-saving drugs accessible to the masses at cheaper costs.

The new system, which is based on Schizosaccharomyces pombe commonly known as fission yeast, has great potential to produce vaccines like Hepatitis B surface antigen vaccine (HBS) and other therapeutic proteins at a lower cost than that produced in Pichia. This technology can be extended to produce other proteins, like Erythropoietin, antibodies, etc.

The current cost of hepatitis B vaccine in India ranges from Rs. 45 (Serum Institute) to Rs. 250 per paediatric dose of 10 microgram in 0.5 ml. In USA it is about $25 per dose. The cost of adult dose of 20 microgram is nearly double. The normal regimen of vaccination involves 3 such injections. The indigenous technology would bring down the cost to less than Rs. 10, when commercially produced.

India has over 40 million Hepatitis B infected patients, second only to China.

Most Hepatitis B patients are unaware of their infection, putting them at serious risk of developing cirrhosis or liver cancer, which is life-threatening.

Similarly, the price of insulin varies from Rs. 140 to Rs. 325/- per injection in India, while in USA it is about $13 per injection. The slow release variant of insulin called Glargine costs from Rs. 410 to 1475 in India and $250-$275 for a 10 ml vial in USA and Canada.

This would be brought down to a third, once the technology developed by IMTECH is commercialised.

"So far we have expressed hepatitis B vaccine at bench scale in fission yeast. Once the production is scaled up, the production cost could be around Re. 1 per dose, while the lowest cost reported for Pichia-based system Rs. 45/- dose," Singh said.

Adding, "Even this is beyond the reach of people below poverty line. Thus, there is scope to bring the commercial price of Hepatitis B vaccine further down. Once the proof-of- concept stage is complete, we will undertake expression of other proteins like insulin, antibodies, etc in fission yeast."

The worldwide market of recombinant Hepatitis B (HBS) vaccine is more than US$ 3.2 billion. The market for anticancer monoclonal antibodies is even bigger and growing.

However, most of the technologies or products are imported. Furthermore, currently popular system of Pichia is patented. This implies payment of large fees by the Indian Biotech companies to the inventor, which adds to the cost of the vaccine.

Pichia vector is generally licensed for commercial research for USD 50,000 with an annual maintenance fee of $ 5,000-30,000. In case the product is commercialized the fee is $75,000 plus royalty ranging from 3-5%," he said.

"While providing protein drugs at lower cost, it would also be a money generator if the technology is commercially exploited worldwide. This is a timely invention as Indian Biotech Industry is poised to enter the multibillion dollar market of biosimilar therapeutic proteins," he concluded. (ANI)

New Delhi [India], Feb. 22 (ANI): In rarest of its kind, a paediatric surgery performed by doctors at a city-based hospital gave a new lease of life to a newborn, suffering from a life-threatening defect of the alimentary canal.

Full Story >>

Beware! Zika can be a reason for miscarriage

Updated: Feb 22, 2017 14:18 IST

Washington D.C. (USA), Feb. 22 (ANI): Beware to-be mothers! According to a recent study, Zika virus could lead to a greater risk of miscarriage in the early stage of pregnancy.

Full Story >>

Washington D.C. (USA), Feb. 22 (ANI): Women with a rare type of epithelial ovarian or peritoneum cancer, can now take sigh of relief.

Full Story >>

Washington D.C. [USA], Feb. 22 (ANI): Now don't blame those chips and chocolates for you childs extra pounds, as a study says around 35-40 percent of a child's is inherited from their parents.

Full Story >>

Drinking too much may age arteries over time!

Updated: Feb 22, 2017 06:03 IST

Washington D.C. [USA], Feb. 22 (ANI): Excessive boozing over the years might age arteries prematurely, especially in men, putting them at an increased risk for heart disease.

Full Story >>

Chronic knee pain may be treated online

Updated: Feb 21, 2017 06:41 IST

Washington D.C. [USA], Feb. 21 (ANI): A study has found out that an online intervention, combining home exercise and pain-coping skills training, provided substantial clinical benefits for patients suffering from chronic knee pain.

Full Story >>

Washington D.C. [USA], Feb. 21 (ANI): Only exercise is not enough to maintain that figure, which is an after effect of much toil and sweat!

Full Story >>

New Delhi [India], Feb. 20 (ANI): With rising life expectancy, increasingly sedentary lifestyles and surge in incidence of obesity, India is also witnessing a resultant rise in orthopedic problems as a natural corollary.

Full Story >>

Children inherit obesity from parents: Study

Updated: Feb 20, 2017 14:54 IST

Washington D.C. (USA), Feb. 20 (ANI): A study reveals that 35-40 percent of a child's 'Body Mass Index' - how fat or thin they are - is inherited from their parents.

Full Story >>

New Delhi [India], Feb 20. (ANI): Good news for all those lazy-headed not-really-a-cleanliness-freak out there! Scientists have found out that the obsession with hygiene could even be turning some beneficial bacteria found in the human gut into "endangered species".

Full Story >>

New Delhi [India], Feb 20. (ANI): In order to persuade someone to quit smoking, it is the 'emotions' that need to be triggered rather than inciting fear in an individual.

Full Story >>

No difference between good or bad diet: Study

Updated: Feb 20, 2017 05:54 IST

New Delhi [India], Feb 20. (ANI): Ever faced a choice between Brown and white bread?

Full Story >>

Washington D.C. [USA], Feb. 19 (ANI): To boost sustainability of livestock production, a study finds that gene editing - one of the newest and most promising tools of biotechnology - enables animal breeders to make beneficial genetic changes, without bringing along unwanted genetic changes.

Full Story >>

People with ADHD may have smaller brain volume

Updated: Feb 19, 2017 07:09 IST

New Delhi [India], Feb 19. (ANI): In a latest study it has been found out that people diagnosed with attention deficit hyperactivity disorder (ADHD) have smaller brain volume than those without the disorder.

Full Story >>

New Delhi [India], Feb 19. (ANI): What if we tell you that scientists can actually slow down the process of ageing. Sounds too good to be true right?

Full Story >>

New Delhi [India], Feb 19. (ANI): Lefty or righty? Well it was decided when you were still in your mum's womb!

Full Story >>

Dads-to be face greater risk of depression

Updated: Feb 19, 2017 06:53 IST

New Delhi [India], Feb 19. (ANI): Expecting a baby is always a joyous experience for both the mother and the father, however a latest study has found out that fathers-to-be can be at risk of depression symptoms if they feel stressed or are in poor health.

Full Story >>

New Delhi [India], Feb 19. (ANI): Do you find it difficult hearing out people at a noisy bar or a restaurant even though you have passed the hearing test with flying colors? Well, you might be secretly deaf!

Full Story >>

New Delhi [India], Feb 19. (ANI): What if we told you that rice has the potential of carrying arsenic and is more than hazardous to feed it to infants!

Full Story >>

Washington D.C. [USA], Feb. 18 (ANI): Now you can save your kid from surgery, as a study shows that antibiotics may be an effective treatment for acute non-complicated appendicitis in children, instead of surgery.

Full Story >>